ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,797,540 | -17.7% | 397,846 | -6.7% | 0.01% | -15.4% |
| Q2 2023 | $13,113,745 | +10.4% | 426,602 | +29.3% | 0.01% | 0.0% |
| Q1 2023 | $11,883,415 | -53.1% | 329,820 | -48.5% | 0.01% | -53.6% |
| Q4 2022 | $25,321,413 | -7.6% | 640,724 | -6.0% | 0.03% | -15.2% |
| Q3 2022 | $27,394,000 | +330.9% | 681,786 | +350.8% | 0.03% | +371.4% |
| Q2 2022 | $6,358,000 | +100.8% | 151,248 | +86.0% | 0.01% | +133.3% |
| Q1 2022 | $3,167,000 | +42.9% | 81,301 | +50.3% | 0.00% | +50.0% |
| Q2 2021 | $2,217,000 | – | 54,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |